Natural Health Trends Corp
NASDAQ:NHTC

  • LAST PRICE
    5.4900
  • TODAY'S CHANGE (%)
    -0.0300 (-0.5435%)
  • Bid / Lots
    5.3300/ 1
  • Ask / Lots
    5.8900/ 1
  • Open / Previous Close
    5.5200 / 5.5200
  • Day Range
    5.4000
    5.6700
  • 52 Week Range
    5.2600
    7.4000
  • Volume
    20,313

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Oct 30, 2024

      Show headlines and story abstract

    • 9:01AM ET on Wednesday Oct 30, 2024 by MT Newswires
      Companies Mentioned: NHTC
      09:01 AM EDT, 10/30/2024 (MT Newswires) -- ...

    • 9:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: NHTC
      (In thousands, except per share data) Three Months Ended September Nine Months Ended 30, September 30, ----------------- ----------------- 2024 2023 2024 2023 ------- ------- ------- ------- Net sales $10,691 $10,615 $32,117 $32,987 Cost of sales 2,765 2,689 8,376 8,386 ------ ------ ------ ------ Gross profit 7,926 7,926 23,741 24,601 Operating expenses: Commissions expense 4,333 4,361 13,022 13,861 Selling, general and administrative expenses 3,868 3,857 11,597 12,169 ------ ------ ------ ------ Total operating expenses 8,201 8,218 24,619 26,030 ------ ------ ------ ------ Loss from operations (275) (292) (878) (1,429) Other income, net 441 585 1,523 1,708 ------ ------ ------ ------ Income before income taxes 166 293 645 279 Income tax provision 131 121 249 69 ------ ------ ------ ------ Net income $ 35 $ 172 $ 396 $ 210 ====== ====== ====== ====== Net income per common share: Basic $ 0.00 $ 0.02 $ 0.03 $ 0.02 ====== ====== ====== ====== Diluted $ 0.00 $ 0.02 $ 0.03 $ 0.02 ====== ====== ====== ====== Weighted average common shares outstanding: Basic 11,471 11,440 11,464 11,432 ====== ====== ====== ====== Diluted 11,490 11,454 11,488 11,449 ====== ====== ====== ====== NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) Nine Months Ended September 30, --------------------------------------- 2024 2023 ----------------- ---------------- CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 396 $ 210 Adjustments to reconcile net income to net cash used in operating activities: Depreciation and amortization 100 130 Net accretion of marketable securities (350) -- Share-based compensation 109 123 Noncash lease expense 825 830 Deferred income taxes 62 (117) Changes in assets and liabilities: Inventories 619 (420) Other current assets (110) (425) Other assets (250) (92) Accounts payable (441) (141) Income taxes payable (3,738) (2,923) Accrued commissions (34) (315) Other accrued expenses 179 (58) Deferred revenue 641 674 Amounts held in eWallets (501) (725) Operating lease liabilities (851) (812) Other current liabilities (111) (148) ------------- ------------ Net cash used in operating activities (3,455) (4,209) ------------- ------------ CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (37) (32) Purchases of marketable securities (44,839) -- Proceeds from maturities of marketable securities 21,786 -- ------------- ------------ Net cash used in investing activities (23,090) (32) ------------- ------------ CASH FLOWS FROM FINANCING ACTIVITIES: Dividends paid (6,909) (6,911) ------------- ------------ Net cash used in financing activities (6,909) (6,911) ------------- ------------ Effect of exchange rates on cash, cash equivalents and restricted cash 174 (145) ------------- ------------ Net decrease in cash, cash equivalents and restricted cash (33,280) (11,297) CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 56,217 69,746 ------------- ------------ CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period $ 22,937 $ 58,449 ============= ============ SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: Right-of-use assets obtained in exchange for operating lease liabilities $ 191 $ 115

    • 9:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: NHTC
      (In thousands, except per share data) Three Months Ended September Nine Months Ended 30, September 30, ----------------- ----------------- 2024 2023 2024 2023 ------- ------- ------- ------- Net sales $10,691 $10,615 $32,117 $32,987 Cost of sales 2,765 2,689 8,376 8,386 ------ ------ ------ ------ Gross profit 7,926 7,926 23,741 24,601 Operating expenses: Commissions expense 4,333 4,361 13,022 13,861 Selling, general and administrative expenses 3,868 3,857 11,597 12,169 ------ ------ ------ ------ Total operating expenses 8,201 8,218 24,619 26,030 ------ ------ ------ ------ Loss from operations (275) (292) (878) (1,429) Other income, net 441 585 1,523 1,708 ------ ------ ------ ------ Income before income taxes 166 293 645 279 Income tax provision 131 121 249 69 ------ ------ ------ ------ Net income $ 35 $ 172 $ 396 $ 210 ====== ====== ====== ====== Net income per common share: Basic $ 0.00 $ 0.02 $ 0.03 $ 0.02 ====== ====== ====== ====== Diluted $ 0.00 $ 0.02 $ 0.03 $ 0.02 ====== ====== ====== ====== Weighted average common shares outstanding: Basic 11,471 11,440 11,464 11,432 ====== ====== ====== ====== Diluted 11,490 11,454 11,488 11,449 ====== ====== ====== ====== NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) Nine Months Ended September 30, --------------------------------------- 2024 2023 ----------------- ---------------- CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 396 $ 210 Adjustments to reconcile net income to net cash used in operating activities: Depreciation and amortization 100 130 Net accretion of marketable securities (350) -- Share-based compensation 109 123 Noncash lease expense 825 830 Deferred income taxes 62 (117) Changes in assets and liabilities: Inventories 619 (420) Other current assets (110) (425) Other assets (250) (92) Accounts payable (441) (141) Income taxes payable (3,738) (2,923) Accrued commissions (34) (315) Other accrued expenses 179 (58) Deferred revenue 641 674 Amounts held in eWallets (501) (725) Operating lease liabilities (851) (812) Other current liabilities (111) (148) ------------- ------------ Net cash used in operating activities (3,455) (4,209) ------------- ------------ CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (37) (32) Purchases of marketable securities (44,839) -- Proceeds from maturities of marketable securities 21,786 -- ------------- ------------ Net cash used in investing activities (23,090) (32) ------------- ------------ CASH FLOWS FROM FINANCING ACTIVITIES: Dividends paid (6,909) (6,911) ------------- ------------ Net cash used in financing activities (6,909) (6,911) ------------- ------------ Effect of exchange rates on cash, cash equivalents and restricted cash 174 (145) ------------- ------------ Net decrease in cash, cash equivalents and restricted cash (33,280) (11,297) CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 56,217 69,746 ------------- ------------ CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period $ 22,937 $ 58,449 ============= ============ SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: Right-of-use assets obtained in exchange for operating lease liabilities $ 191 $ 115

Peers Headlines